| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a22763de32ac2b8f6334eeeacae99e4a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6845 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6845 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2001-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe3dd943b6477417571c229a647d902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec99ff8d2ebebc20767baf958ebae1bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b94c59fed4da944ad626d232ec21701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1a113d208b4e44de7fd5253dbae0d1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62f556ea3f404bec472d2f1f21319839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f95e67876b161ff08b26a1f2d9bf6de |
| publicationDate |
2007-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2230975-B2 |
| titleOfInvention |
"ANTIBODY MOLECULES THAT HAVE SPECIFICITY FOR THE HUMAN ALPHA TUMOR NECOSIS FACTOR AND USE OF THE SAME". |
| abstract |
Antibody molecules that have specificitynby the human tumor necrosis factor? and use ofnsame.n n n Antibody molecules are described whichncontain at least one CDR from a monoclonal antibodynof mouse that has specificity for human TNFα. Toona grafted CDR antibody is described in which at least onenof the CDRs is a hybrid CDR. Sequences ofnDNA encoding the chains of antibody molecules,nvectors, transformed host cells and uses of the molecules ofnantibody in the treatment of diseases mediated bynTNFαp. |
| priorityDate |
2000-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |